{"cluster": 32, "subcluster": 2, "abstract_summ": " The value of extracorporeal membrane oxygenation (ECMO) for patients suffering from novel coronavirus disease 2019 (COVID-19) as a rescue therapy for respiratory failure remains controversial and associated with high mortality rates of 50 to 82% in early reports from Wuhan, China . A 51-year-old healthy female developed severe acute respiratory syndrome . She was treated with ECMO in conjunction with compassionate use antiviral treatment with remdesivir ."}